Statement Of Cash Flows [Abstract]

BioInvent International - Filing #678852

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-01-01
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-01-01
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Interest paid, classified as operating activities
638,000 SEK
650,000 SEK
Interest received, classified as operating activities
19 419 SEK
606,000 SEK
Income taxes paid (refund), classified as operating activities
90,000 SEK
SEK
Cash flows from (used in) operating activities
341 691 SEK
41 227 SEK
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
13 304 SEK
12 377 SEK
Cash flows from (used in) investing activities
59 681 SEK
628 848 SEK
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
30 959 SEK
279 849 SEK
Payments of lease liabilities, classified as financing activities
7 820 SEK
6 362 SEK
Cash flows from (used in) financing activities
23 139 SEK
273 487 SEK
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
258 871 SEK
396 588 SEK
Cash and cash equivalents
259 548 SEK
515 047 SEK
515 047 SEK
910 755 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.